CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]
Net sales	$ 1,913	$ 2,703
Costs and expenses:
Cost of products sold	(569)	(1,437)
Research and development expense	(69,120)	(51,451)
Selling, general and administrative expense	(26,118)	(28,187)
Operating loss	(93,894)	(78,372)
Other non-operating income, net	467	2,442
Interest and amortization of debt discount and expense	(73)	(47)
Net foreign exchange (losses)/gains	(744)	1,440
Debt issuance costs	0	(465)
Loss on debt extinguishment	0	(904)
Fair value movement of derivatives	19	(61)
Loss before income taxes from continuing operations	(94,225)	(75,967)
Income tax (expense)/benefit	0	0
Loss after income tax	(94,225)	(75,967)
Total (loss)/gain is attributable to:
Non-controlling interests	(81)	324
Stockholders of the Company	(94,144)	(76,291)
Loss after income tax	$ (94,225)	$ (75,967)
Share information
Basic loss per share (in Dollars per share)	$ (2.55)	$ (3.68)
Diluted loss per share (in Dollars per share)	$ (2.55)	$ (3.68)